ICON Launches New Patient Safety Service for Real-Time Analysis of Aggregated Safety Data

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today launched ICONIK Patient Safety, the latest service to leverage its ICONIK technology platform. Identifying potentially significant clinical issues in real-time, ICONIK Patient Safety offers a systematic way to monitor safety trends in accumulating data, spot potential safety issues and take appropriate corrective and preventative action while the study is on-going. Data can be queried dynamically at any level of detail (single patient, single site, across an entire study or entire compound), helping sponsors make informed, data driven decisions regarding patient treatment and safety, study direction and regulatory reporting. ICONIK Patient Safety eliminates the lengthy, manual review of individual patient files, allowing a faster and easier review of aggregated safety events across study populations.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC